Researchers presented new findings Saturday at a breast-cancer symposium here suggesting that the risks associated with anthracyclines, a class of chemotherapy drugs widely used to treat the disease, outweighed their benefits in some patients.The findings renewed a debate over whether anthracyclines, which have been around since the 1960s, should remain the standard of care in treating breast cancer, or whether newer drugs should be used more frequently instead.
More...
US healthcare officials recently said a food-poisoning outbreak tied to alfalfa sprouts and involving multiple germs...
Common personal care products widely contain unlabeled toxic chemicals, results from a new peer-reviewed study suggest....
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable...
